Survival of patients who develop solid tumors following hematopoietic stem cell transplantation

Allogeneic hematopoietic cell transplantation is associated with late adverse effects of therapy, including secondary solid cancers. Most reports address risk factors; however outcomes after secondary solid cancer development are incompletely described. Our objective was to estimate survival probabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhardt, Matthew J, Brazauskas, Ruta, He, Wensheng, Rizzo, J Douglas, Shaw, Bronwen E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570237/
https://www.ncbi.nlm.nih.gov/pubmed/26367222
http://dx.doi.org/10.1038/bmt.2015.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570237/
https://www.ncbi.nlm.nih.gov/pubmed/26367222
http://dx.doi.org/10.1038/bmt.2015.203

Ejemplares similares